Marshall Wace »

Janux Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 48k 45.43

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Microsoft Corp Common Stock (MSFT)
Amazon.com Equity Option Put Option (AMZN)
Apple Common Stock (AAPL)
Meta Platforms-a Common Stock (META)
Nvidia Corp Common Stock (NVDA)
Alphabet Inc-a Common Stock (GOOGL)
Tesla Common Stock (TSLA)
Flutter Enter-di Common Stock (FLUT)
Johnson&johnson Common Stock (JNJ)
Eli Lilly & Co Common Stock (LLY)
Boston Scientifc Common Stock (BSX)
Broadcom Common Stock (AVGO)
Spdr Gold Trust Equity Option Call Option (GLD)

View all positions for Marshall Wace

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics